{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T22:45:12Z","timestamp":1766270712818,"version":"3.48.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"vor","delay-in-days":347,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The SARS-CoV-2 pandemic caused an estimated 400 million people worldwide to experience Long COVID and post-COVID complications leading to significant chronic illness and disability with its devastating physical, societal and economic consequences. Since post-acute infectious syndromes have not been given adequate consideration prior to the pandemic, many millions of people with Long COVID worldwide have been left disabled as currently available therapies are largely symptomatic and only partially effective. A case of a previously healthy woman with Long COVID and post-COVID autonomic dysfunction and myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) is presented here from the perspective of a physician-patient relationship and a broader context of medical care and public health. Immunologic and autonomic mechanistic factors and therapies as these relate to Long COVID are highlighted. Complexities and issues pertaining to patient care, public health and education of neurologists and other specialists regarding Long COVID, dysautonomia and ME\/CFS diagnosis and treatment are discussed, in conjunction with the need to develop and diversify effective therapies for people living with these highly disabling conditions.<\/jats:p>","DOI":"10.1093\/oxfimm\/iqaf010","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:14:01Z","timestamp":1765372441000},"source":"Crossref","is-referenced-by-count":0,"title":["Long COVID: a long road ahead"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3982-2031","authenticated-orcid":false,"given":"Svetlana","family":"Blitshteyn","sequence":"first","affiliation":[{"name":"Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo , Buffalo, NY,","place":["USA"]},{"name":"Dysautonomia Clinic , Williamsville, NY,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"key":"2025122017415332500_iqaf010-B1","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1038\/s41591-024-03173-6","article-title":"Long COVID science, research and policy","volume":"30","author":"Al-Aly","year":"2024","journal-title":"Nat Med"},{"year":"2022","author":"National Center for Health Statistics","key":"2025122017415332500_iqaf010-B2"},{"key":"2025122017415332500_iqaf010-B3","doi-asserted-by":"publisher","first-page":"1090747","DOI":"10.3389\/fneur.2023","article-title":"Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): results from a post-COVID-19 multidisciplinary clinic","volume":"14","author":"Bonilla","year":"2023","journal-title":"Front Neurol"},{"key":"2025122017415332500_iqaf010-B4","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3390\/jpm14080799","article-title":"Long COVID is not a functional neurologic disorder","volume":"14","author":"Davenport","year":"2024","journal-title":"J Pers Med"},{"key":"2025122017415332500_iqaf010-B5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3390\/biomedicines13010166","article-title":"Neuroinflammation at the dorsolateral inferior medulla: a possible central nervous system localization for POTS and Long COVID","volume":"13","author":"Blitshteyn","year":"2025","journal-title":"Biomedicines"},{"key":"2025122017415332500_iqaf010-B6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41582-023-00917-9","article-title":"Post-COVID dysautonomias: what we know and (mainly) what we don\u2019t know","volume":"20","author":"Goldstein","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"2025122017415332500_iqaf010-B7","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41586-024-07469-y","article-title":"A body\u2013brain circuit that regulates body inflammatory responses","volume":"630","author":"Jin","year":"2024","journal-title":"Nature"},{"key":"2025122017415332500_iqaf010-B8","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nrendo.2012.189","article-title":"The vagus nerve and the inflammatory reflex\u2014linking immunity and metabolism","volume":"8","author":"Pavlov","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"2025122017415332500_iqaf010-B9","doi-asserted-by":"publisher","first-page":"104622","DOI":"10.1016\/j.neubiorev.2022.104622","article-title":"The cholinergic anti-inflammatory pathway in humans: State-of-the-art review and future directions","volume":"136","author":"Alen","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"2025122017415332500_iqaf010-B10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/ijerph22020275","article-title":"Language matters: what not to say to patients with Long COVID, Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome, and other complex chronic disorders","volume":"22","author":"Smyth","year":"2025","journal-title":"Int J Environ Res Public Health"},{"key":"2025122017415332500_iqaf010-B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-020-02683-4","article-title":"The evidence base for physiotherapy in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome when considering post-exertional malaise: a systematic review and narrative synthesis","volume":"19","author":"Wormgoor","year":"2021","journal-title":"J Transl Med"},{"key":"2025122017415332500_iqaf010-B12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"2025122017415332500_iqaf010-B13","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/pmrj.12894","article-title":"Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of autonomic dysfunction in patients with post-acute sequelae of SARS-CoV-2 infection (PASC)","volume":"14","author":"Blitshteyn","year":"2022","journal-title":"PM R"},{"year":"2024","author":"NIH opens Long COVID trials to evaluate treatments for autonomic nervous system dysfunction","key":"2025122017415332500_iqaf010-B14"},{"key":"2025122017415332500_iqaf010-B15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12941-025-00793-9","article-title":"Long COVID clinical evaluation, research and impact on society: a global expert consensus","volume":"24","author":"Ewing","year":"2025","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2025122017415332500_iqaf010-B16","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/s41591-024-02987-8","article-title":"Three-year outcomes of post-acute sequelae of COVID-19","volume":"30","author":"Cai","year":"2024","journal-title":"Nat Med"},{"key":"2025122017415332500_iqaf010-B17","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1038\/s41591-022-02051-3","article-title":"Acute and postacute sequelae associated with SARS-CoV-2 reinfection","volume":"28","author":"Bowe","year":"2022","journal-title":"Nat Med"},{"key":"2025122017415332500_iqaf010-B18","doi-asserted-by":"publisher","first-page":"102815","DOI":"10.1016\/j.eclinm.2024.102815","article-title":"Characteristics and predictors of Long Covid in children: a 3-year prospective cohort study","volume":"76","author":"Camporesi","year":"2024","journal-title":"eClinicalMedicine"},{"key":"2025122017415332500_iqaf010-B19","doi-asserted-by":"publisher","first-page":"167563","DOI":"10.1016\/j.bbadis.2024.167563","article-title":"Linking COVID-19 and cancer: underlying mechanism","volume":"1871","author":"Tyagi","year":"2025","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2025122017415332500_iqaf010-B20","doi-asserted-by":"publisher","first-page":"1471192","DOI":"10.3389\/fncel.2024.1471192","article-title":"The impact of COVID-19 on accelerating of immunosenescence and brain aging","volume":"18","author":"M\u00fcller","year":"2024","journal-title":"Front Cell Neurosci"},{"key":"2025122017415332500_iqaf010-B21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12026-025-09661-2","article-title":"Dysautonomia: a common comorbidity of systemic disease","volume":"73","author":"Blitshteyn","year":"2025","journal-title":"Immunol Res"},{"key":"2025122017415332500_iqaf010-B22","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1212\/WNL.0000000000207739","article-title":"The brain health imperative in the 21st century-a call to action: the AAN Brain Health Platform and position statement","volume":"101","author":"Rost","year":"2023","journal-title":"Neurology"},{"key":"2025122017415332500_iqaf010-B23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40798-024-00695-8","article-title":"Practical recommendations for exercise training in patients with Long COVID with or without post-exertional Malaise: a best practice proposal","volume":"10","author":"Gloeckl","year":"2024","journal-title":"Sports Med Open"},{"key":"2025122017415332500_iqaf010-B24","doi-asserted-by":"publisher","first-page":"e254415","DOI":"10.1001\/jamaneurol.2025.4415","article-title":"Evaluation of interventions for cognitive symptoms in Long COVID: a randomized clinical trial","volume":"10","author":"Knopman","year":"2025","journal-title":"JAMA Neurol"},{"key":"2025122017415332500_iqaf010-B25","doi-asserted-by":"publisher","first-page":"1647203","DOI":"10.3389\/fcimb.2025.1647203","article-title":"Immunotherapies for postural orthostatic tachycardia syndrome, other common autonomic disorders and Long COVID: current state and future direction","volume":"15","author":"Blitshteyn","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"year":"2024","author":"RECOVER-AUTONOMIC Study Group A: IVIG or Placebo","key":"2025122017415332500_iqaf010-B26"}],"container-title":["Oxford Open Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ooim\/advance-article-pdf\/doi\/10.1093\/oxfimm\/iqaf010\/65878401\/iqaf010.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ooim\/article-pdf\/6\/1\/iqaf010\/65878401\/iqaf010.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ooim\/article-pdf\/6\/1\/iqaf010\/65878401\/iqaf010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T22:41:57Z","timestamp":1766270517000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ooim\/article\/doi\/10.1093\/oxfimm\/iqaf010\/8379704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2,3]]}},"URL":"https:\/\/doi.org\/10.1093\/oxfimm\/iqaf010","relation":{},"ISSN":["2633-6960"],"issn-type":[{"type":"electronic","value":"2633-6960"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"iqaf010"}}